Literature DB >> 31076796

[Importance of psychosomatic medicine for people with rare diseases].

B Kolb-Niemann1, J Kruse2.   

Abstract

People with rare diseases have a very high rate of mental and social stress. This results in specific tasks and problems in the psychosomatic care of patients. On the one hand, the physical and/or psychological symptoms of an undetected rare organic disease can be misdiagnosed as a psychosomatic disease, and the affected persons possibly receive psychotherapy that is not causally effective. On the other hand, mental diseases that require treatment can arise as a result of the effects of a rare disease. These should be diagnosed as such and treated with psychotherapy. If, in individual cases, both symptoms of a rare disease and symptoms of a psychosomatic disorder in the sense of comorbidity are present, neither one nor the other diagnosis should lead to a hasty termination of diagnostic efforts. Otherwise, misalignments can easily occur and the further diagnostic and therapeutic process can be permanently disturbed. Interdisciplinary team care interventions should therefore be developed further.

Entities:  

Keywords:  Diagnosis by exclusion; Interdisciplinary care team; Psychosomatic disorders; Rare diseases, diagnostic errors; Simultaneous diagnostics

Mesh:

Substances:

Year:  2019        PMID: 31076796     DOI: 10.1007/s00108-019-0613-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  9 in total

1.  Clinical presentation in female patients with Fabry disease.

Authors:  N Guffon
Journal:  J Med Genet       Date:  2003-04       Impact factor: 6.318

Review 2.  The challenge of diagnosing non-specific, functional, and somatoform disorders: A systematic review of barriers to diagnosis in primary care.

Authors:  Alexandra M Murray; Anne Toussaint; Astrid Althaus; Bernd Löwe
Journal:  J Psychosom Res       Date:  2015-11-07       Impact factor: 3.006

3.  Duration of untreated illness in patients with somatoform disorders.

Authors:  Annabel Herzog; Meike C Shedden-Mora; Pascal Jordan; Bernd Löwe
Journal:  J Psychosom Res       Date:  2018-01-31       Impact factor: 3.006

4.  [The future of psychotherapy in psychosomatic medicine].

Authors:  Manfred E Beutel; Johannes Kruse; Matthias Michal; Wolfgang Herzog
Journal:  Z Psychosom Med Psychother       Date:  2013       Impact factor: 0.791

5.  Depression as a risk factor for mortality in individuals with diabetes: a meta-analysis of prospective studies.

Authors:  Mareike Hofmann; Birgit Köhler; Falk Leichsenring; Johannes Kruse
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

6.  Characteristics of patients contacting a center for undiagnosed and rare diseases.

Authors:  Tobias Mueller; Andreas Jerrentrup; Max Jakob Bauer; Hans Walter Fritsch; Juergen Rolf Schaefer
Journal:  Orphanet J Rare Dis       Date:  2016-06-21       Impact factor: 4.123

Review 7.  Living with a rare disorder: a systematic review of the qualitative literature.

Authors:  Charlotte von der Lippe; Plata S Diesen; Kristin B Feragen
Journal:  Mol Genet Genomic Med       Date:  2017-07-23       Impact factor: 2.183

8.  Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis.

Authors:  Michael Beck; Derralynn Hughes; Christoph Kampmann; Sylvain Larroque; Atul Mehta; Guillem Pintos-Morell; Uma Ramaswami; Michael West; Anna Wijatyk; Roberto Giugliani
Journal:  Mol Genet Metab Rep       Date:  2015-03-05

9.  Health-related quality of life among adults with diverse rare disorders.

Authors:  Kathleen R Bogart; Veronica L Irvin
Journal:  Orphanet J Rare Dis       Date:  2017-12-07       Impact factor: 4.123

  9 in total
  1 in total

Review 1.  [ZSE-DUO - dual guidance structure at the centre for rare diseases].

Authors:  C Schippers; D Volk; M de Zwaan; J Deckert; J Dieris-Hirche; S Herpertz; J B Schulz; H Hebestreit
Journal:  Inn Med (Heidelb)       Date:  2022-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.